Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7486 to 7500 of 8314 results

  1. Living-donor liver transplantation (IPG194)

    Interventional procedures, IPG194 - Issued: November 2006 --> This guidance has been updated and replaced by NICE interventional procedure guidance 535.

    Interventional procedures guidance
    Published
    22 November 2006

  2. Laparoscopic cerclage for prevention of recurrent pregnancy loss due to cervical incompetence (IPG228)

    Interventional procedures, IPG228 - Issued: August 2007 --> This guidance has been updated and replaced by NICE interventional procedures guidance 639.

    Interventional procedures guidance
    Published
    22 August 2007

  3. Intravesical microwave hyperthermia with intravesical chemotherapy for superficial bladder cancer (IPG235)

    Interventional procedures, IPG235 - Issued: October 2007 --> This guidance has been updated and replaced by NICE interventional procedures guidance 628.

    Interventional procedures guidance
    Published
    24 October 2007

  4. Transcranial magnetic stimulation for severe depression (IPG242)

    Interventional procedures, IPG242 - Issued: November 2007 --> This guidance has been updated and replaced by NICE interventional procedure guidance 542.

    Interventional procedures guidance
    Published
    28 November 2007

  5. Canaloplasty for primary open-angle glaucoma (IPG260)

    Interventional procedures, IPG260 - Issued: May 2008 --> This guidance has been updated and replaced by NICE interventional procedures guidance 591. 

    Interventional procedures guidance
    Published
    28 May 2008

  6. Systemic juvenile idiopathic arthritis: canakinumab (ESNM36)

    This evidence summary has been withdrawn. An NHS England clinical commissioning policy statement on biologic therapies for the treatment of juvenile idiopathic arthritis is available.

    Evidence summary
    Published
    18 March 2014

  7. Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system (ESNM41)

    This evidence summary has been replaced by the long-acting reversible contraception: implementation resource summary.

    Evidence summary
    Published
    4 June 2014

  8. Critical limb ischaemia in peripheral vascular disease: intravenous iloprost (ESUOM24)

    April 2019: This evidence summary has been withdrawn because a product containing intravenous iloprost with a marketing authorisation for treating critical limb ischaemia in peripheral vascular disease is now available in the UK.

    Evidence summary
    Published
    17 December 2013

  9. Difficult-to-treat scabies: oral ivermectin (ESUOM29)

    November 2024: This evidence summary has been withdrawn because licensed products are now available.

    Evidence summary
    Published
    18 March 2014

  10. Autologous haematopoietic stem cell transplantation for treating multiple sclerosis [ID1111]

    Discontinued Reference number: GID-TA10306

    Technology appraisal guidance
    Discontinued

  11. Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]

    Discontinued Reference number: GID-TA10334

    Technology appraisal guidance
    Discontinued

  12. Durvalumab with tremelimumab for untreated PD-L1-positive urothelial bladder cancer [ID1335]

    Discontinued Reference number: GID-TA10315

    Technology appraisal guidance
    Discontinued

  13. Veliparib in combination for treating BRCA-positive, HER2-negative breast advanced cancer [ID1404]

    Discontinued Reference number: GID-TA10327

    Technology appraisal guidance
    Discontinued

  14. Entinostat for treating hormone receptor-positive breast cancer after hormonal therapy [ID1260]

    Discontinued Reference number: GID-TA10309

    Technology appraisal guidance
    Discontinued

  15. Pembrolizumab with epacadostat for untreated malignant melanoma [ID1423]

    Discontinued Reference number: GID-TA10330

    Technology appraisal guidance
    Discontinued